Table of Contents
Oils, capsules, edibles, creams, and vapes all deliver CBD — but they differ in how fast they act, how long they last, and whether they reach the whole body or one spot. Before comparing them, the honest starting point: the evidence that CBD helps pain is limited and mixed, no CBD product is approved for pain relief, and the right choice depends on your pain, your medicines, and your tolerance for risk. This guide compares the routes on those terms, with the evidence stated as it is.
What the evidence actually shows
The US National Center for Complementary and Integrative Health summarises the position carefully: some evidence suggests modest benefits of cannabis or cannabinoids for chronic pain and multiple sclerosis symptoms, and research for other conditions is at an early stage. Note the wording — cannabis or cannabinoids, modest, chronic pain. The evidence for CBD specifically, separated from THC, is thinner: mostly laboratory and animal studies plus small human trials, with inconsistent results. Arthritis is a good example of the gap: the human evidence is early and mostly preclinical, not the basis for a recommendation. No CBD product is FDA-approved for pain; the only approved CBD medicine, Epidiolex, is for certain seizure disorders. Anyone selling CBD as a proven pain treatment is ahead of the evidence. Read the NCCIH summary before deciding, and talk to a clinician — especially if you take other medicines, because CBD affects the liver enzymes (CYP450) that process many drugs.
How the routes compare
| Route | Onset | Duration | Reach | Main trade-off |
|---|---|---|---|---|
| Topical (cream, salve) | 15–45 minutes | A few hours | Local — the application area | Weakest evidence; minimal systemic effect |
| Sublingual oil | 15–45 minutes | 4–6 hours | Whole body | Taste; dose precision depends on the dropper |
| Oral (capsule, edible) | 1–2 hours | 6–8 hours | Whole body | Slowest onset; first-pass metabolism reduces the dose that reaches the blood |
| Inhaled (vape, smoke) | Minutes | 2–3 hours | Whole body | Fastest — and the lung risks that come with inhalation |
These are typical ranges, not guarantees: onset and duration vary with dose, formulation, food intake, and the individual. If a product promises exact timing, it is promising more than the evidence supports.
Full-spectrum, broad-spectrum, or isolate?
Full-spectrum products contain CBD plus other hemp compounds, including trace THC. Broad-spectrum products contain other cannabinoids with the THC removed (or reduced to undetectable levels). Isolate is pure CBD. The difference that matters most is THC: full-spectrum products carry a drug-test risk and, at high doses, a small intoxication risk from the THC content. The often-cited “entourage effect” — the idea that the compounds work better together — is a hypothesis, unproven in humans; do not let it decide your purchase. What should decide it is the certificate of analysis: check CBD and total THC content for the specific batch. See CBD isolate vs shatter and CBD oil vs gummies for deeper comparisons.
Topicals: local action, limited evidence
Creams, salves, and balms are applied to the skin over the painful area. Standard topicals act locally with minimal absorption into the bloodstream — which is why they are popular for joint and muscle pain, and also why their effects, if any, stay local. The exception is transdermal patches, which are designed to deliver CBD through the skin into the bloodstream; do not confuse the two. Practical points: apply to clean skin, use enough to cover the area, and give it time — effects, if felt, build over tens of minutes. The human evidence for topical CBD and pain is thin; anecdote is not evidence, and a warming or cooling sensation from menthol or other ingredients is not the CBD working.
Oral CBD: slower, longer, more variable
Oils held under the tongue absorb partly through the mouth’s tissues and partly through digestion; capsules and edibles go entirely through digestion, where first-pass metabolism in the liver reduces the amount of CBD that reaches the bloodstream and delays onset to one or two hours. The trade-off is duration: oral forms typically last longest. There is no established dose of CBD for pain — studies use widely varying doses, and product labels are not dosing guidance. The general principle is to start low, increase slowly if needed, track what happens, and stop if side effects appear. Drowsiness, diarrhoea, appetite changes, and liver-enzyme effects are the documented risks; CBD’s interaction with other medicines is the most important one. A clinician who knows your medicines is the right person to advise on dose — not a product label and not this guide.
Inhalation: fastest onset, real lung risks
Vaping or smoking CBD delivers it to the bloodstream within minutes, which is why inhalation appeals for sudden pain. The cost is the lungs: smoking any plant material produces harmful combustion products, and vaping carries its own risks, including poorly regulated cartridges and additives. The 2019 lung-injury outbreak (EVALI) was linked to vitamin E acetate in illicit THC cartridges, not to CBD — but it remains a warning about unregulated vape products generally. If you have any lung condition, or you do not already vape or smoke, inhalation is the worst route to start with. See CBD dabs for the concentrated-inhalation picture, and CBD for anxiety relief for the related evidence discussion.
Choosing: a checklist, not a prescription
| Question | Why it matters |
|---|---|
| Localised or widespread pain? | Localised pain suits a topical trial; widespread pain needs a systemic route |
| Do you take prescription medicines? | CBD interacts with CYP450-processed drugs — clinician advice first |
| Does drug testing matter? | Full-spectrum products can trigger positive THC tests; isolate is lower risk, not risk-free |
| Is there a batch-matched COA? | Lab testing has repeatedly found mislabelled products — no COA, no purchase |
| Are the claims modest? | ‘Clinically proven’, ‘cures’, or guaranteed relief are red flags |
For the full category, see the CBD Guides hub.
The Johnson et al. 2023 labeling study tested 53 hemp Delta-9 products and found 66% off-label by more than 10%.
Frequently asked questions
What is CBD’s role in pain management?
Unproven as a treatment. Some evidence suggests modest benefits of cannabis or cannabinoids for chronic pain; the CBD-specific evidence is thinner. No CBD product is approved for pain.
How do CBD oils compare to topicals for pain?
Oils reach the whole body and last longer; topicals act locally with minimal systemic absorption. Neither has strong human evidence for pain.
Are there CBD products for chronic pain relief?
Many products are marketed for chronic pain, but marketing is not evidence. Discuss options — including non-CBD ones — with a clinician before relying on any CBD product.
Do CBD edibles provide long-lasting pain relief?
Edibles last longest of the oral forms, typically several hours, with the slowest onset. Whether they relieve pain in a given person is unproven.
Can CBD products alleviate arthritis pain?
The evidence is early and mostly preclinical. Small human studies exist but do not support a recommendation. Consult a clinician, especially if you take arthritis medication.
Affiliate Disclosure
The CakeHeights Editorial Team is committed to providing accurate, research-backed information about cannabis and hemp products. Some links on this page are affiliate links, meaning we may earn a commission at no extra cost to you if you make a purchase through them. Our recommendations are based on independent research, testing, and analysis. We only promote products we believe offer genuine value to our readers. Learn more →
Leave a Reply